Avian influenza and Newcastle disease virusindead chickens in markets in Dhaka, Bangladesh in 2011-2012 von Barman, LR, Sarker, RD, Das, BC, Chowdhury, EH, Das, PM, Islam, MR

Volltext

Abstract P4-14-26: Phase I expansion of S-222611, a reversible inhibitor of EGFR and HER2, in advanced solid tumors, including HER2-positive breast cancer patients with brain metas... von Baird, RD, Arkenau, H-T, Deva, S, Cresti, N, Garcia-Corbacho, J, Hogarth, L, Frenkel, E, Kawaguchi, K, Arimura, A, Donaldson, K, Posner, J, Sarker, D, Jodrell, D, Plummer, R, Spicer, J, Italiano, A

Volltext

The burden of diseases and risk factors in Bangladesh, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 von Islam, SMS, Uddin, R, Das, S, Ahmed, SI, Zaman, SB, Alif, SM, Hossen, MT, Sarker, M, Siopis, G, Livingstone, KM, Mehlman, ML, Rahman, MM, Chowdhury, RI, Alim, MA, Choudhury, SR, Ahmed, SM, Adhikary, RK, Anjum, A, Banik, PC, Chowdhury, FR, Faruk, MO, Gupta, RD, Hannan, MA, Haque, MN, Haque, SE, Hasan, MT, Hossain, MB, Hossain, MM, Hossain, M, Hossain, S, Hossain, SJ, Khan, MN, Khan, MJ, Mamun, MA, Mokdad, AH, Moni, MA, Murray, CJL, Rahman, M, Ratan, ZA, Ripon, RK, Saif-Ur-Rahman, KM, Sayeed, A, Siraj, MS, Sultana, S, Maddison, R, Hay, SI, Naghavi, M

Volltext bestellen

The effect of imbalance in a just-in-time production system: A simulation study von SARKER, BHABA R., HARRIS, ROY D.

Volltext

Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial von Schmid, P, Abraham, J, Chan, S, Wheatley, D, Brunt, AM, Nemsadze, G, Baird, RD, Park, YH, Hall, PS, Perren, T, Stein, RC, Mangel, L, Ferrero, J-M, Phillips, M, Conibear, J, Cortes, J, Foxley, A, de Bruin, EC, McEwen, R, Stetson, D, Dougherty, B, Sarker, S-J, Prendergast, A, McLaughlin-Callan, M, Burgess, M, Lawrence, C, Cartwright, H, Mousa, K, Turner, NC

Volltext bestellen

Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial von Schmid, P, Abraham, J, Chan, S, Wheatley, D, Brunt, AM, Nemsadze, G, Baird, RD, Park, YH, Hall, PS, Perren, T, Stein, RC, Mangel, L, Ferrero, J-M, Phillips, M, Conibear, J, Cortes, J, Foxley, A, de Bruin, EC, McEwen, R, Stetson, D, Dougherty, B, Sarker, S-J, Prendergast, A, McLaughlin-Callan, M, Burgess, M, Lawrence, C, Cartwright, H, Mousa, K, Turner, NC

Volltext bestellen

First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant Fibroblast Growth Factor 19 Signaling as a Driver Event in Hepatocellular Carcinoma von Kim, RD, Sarker, D, Meyer, T, Yau, T, Macarulla, T, Park, J-W, Choo, SP, Hollebecque, A, Sung, MW, Lim, H-Y, Mazzaferro, V, Trojan, J, Zhu, AX, Yoon, J-H, Sharma, S, Lin, Z-Z, Chan, SL, Faivre, S, Feun, LG, Yen, C-J, Dufour, J-F, Palmer, DH, Llovet, JM, Manoogian, M, Tugnait, M, Stransky, N, Hagel, M, Kohl, NE, Lengauer, C, Sherwin, CA, Schmidt-Kittler, O, Hoeflich, KP, Shi, H, Wolf, BB, Kang, Y-K

Volltext bestellen

Dimeric Products from tert- Butyl(N,N-dimethylamino)carbodiimide von Sarker, Sanchita, Cooley, James H, Willett, Roger D, Rheingold, Arnold L

Volltext